Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Y. Zhang
Observed names:
Y. ZHANG,
Yuelin Zhang
Institution:
Sun Yat-sen University Cancer Center
Observed institutions:
Wayne State University,
Dalian Medical University,
Mianyang Central Hospital,
Second Affiliated Hospital of Dalian Medical University,
Sun Yat-sen University Cancer Center,
University of Warmia and Mazury in Olsztyn,
The Ohio State University,
Xi'an Jiaotong University
show all 8
ORCID:
0000-0002-3152-7468
Observed ORCID:
0000-0002-3152-7468
OpenAlex ID:
A5088771990
Diversity of staphylococcal cassette chromosome in coagulase-negative staphylococci from animal sources: Diversity of SCC in CoNS
2009
·
Y. Zhang
, S. Agidi
, et al.
·
Journal of Applied Microbiology
·
93
Multidrug-resistant coagulase-negative Staphylococci in food animals
2012
·
K. Bhargava
, Y. Zhang
·
Journal of Applied Microbiology
·
67
Free- and peptide-based dietary arginine supplementation for the South American fish pacu (Piaractus mesopotamicus)
2005
·
M.B. TESSER
, B.F. TERJESEN
, et al.
·
Aquaculture Nutrition
·
51
PDF
Characterization of the expression pattern of adrenergic receptors in rat taste buds
2010
·
Y. Zhang
, T. Kolli
, et al.
·
Neuroscience
·
28
Utilization of dipeptide/protein based diets in larval and juvenile Koi carp – post-prandial free amino acid levels
2009
·
K. Kwasek
, Y. Zhang
, et al.
·
Journal of Animal Physiology and Animal Nutrition
·
21
PDF
MONARCHplus: A phase III trial of abemaciclib plus nonsteroidal aromatase inhibitor (NSAI) or fulvestrant (F) for women with HR+/HER2- advanced breast cancer (ABC)
2019
·
Z. Jiang
, X. Hu
, et al.
·
Annals of Oncology
·
15
Differential effect of keratinocyte growth factor (KGF) on aromatase activity in cultured canine prostatic epithelial cells
1997
·
H. Canatan
, F. Shidaifat
, et al.
·
Endocrine Research
·
8
CDK5R1 promotes Schwann cell proliferation, migration, and production of neurotrophic factors via CDK5/BDNF/TrkB after sciatic nerve injury
2023
·
Lei Xia
, Peng Li
, et al.
·
Neuroscience Letters
·
5
959P Combination therapy of envafolimab and suvemcitug in patients with hepatocellular carcinoma (HCC): Results from a phase II clinical trial
2023
·
L. Ma
, Y. Zhang
, et al.
·
Annals of Oncology
·
5
PDF
970P Comparing clinical outcomes between PD-1 and PD-L1 inhibitors plus bevacizumab combined with hepatic arterial interventional therapies in unresectable hepatocellular carcinoma: A single-center, real-world study
2024
·
Y. Pan
, Z. Yuan
, et al.
·
Annals of Oncology
PDF
198P Comparing clinical outcomes between PD-1 and PD-L1 inhibitors plus bevacizumab combined with hepatic arterial interventional therapies in unresectable hepatocellular carcinoma: A single-center, real-world study
2024
·
Z. Yuan
, Y. Pan
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
11
Citation count:
293
H-index:
7
I10-index:
6
Year
Topic
Type